BioXcel Therapeutics (BTAI) PT Lowered to $95 at Canaccord Genuity

April 1, 2021 6:32 AM EDT Send to a Friend

Canaccord Genuity analyst Sumant Kulkarni ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

BioXcel Therapeutics (BTAI) PT Lowered to $95 at Canaccord Genuity

Member Login

Free News Feed